OrbusNeich Begins Important Clinical Trial in Japan for a New Heart Treatment
OrbusNeich, a company that makes medical devices for heart treatments, has just started a major clinical trial in Japan with […]
Pharmaceutical News
Johnson & Johnson Teams Up with Sail Biomedicines to Develop New Treatments for Immune Diseases
Johnson & Johnson, through its subsidiary Janssen Biotech, has partnered with Sail Biomedicines, a U.S. biotechnology company, to develop innovative
New Treatment Recommendation for Severe Itching in Liver Disease: Lynavoy Could Soon Be Available in Europe
A European medical committee has recommended approving a new medication called Lynavoy to treat severe itching in adults with a
Pharmaceutical News
WHO Releases First-Ever Global Plan to Make Medicine Production Greener
The World Health Organization (WHO) has just created the first worldwide recommendations to help medicine regulators speed up the shift
New Treatment Approved for a Specific Type of Advanced Lung Cancer
GlaxoSmithKline (GSK) has received approval from the US Food and Drug Administration (FDA) for a new cancer treatment called Jideytro
Pharmaceutical News
BeOne Medicines Expands New Jersey Facility with $300 Million Investment to Boost Cancer Drug Production
BeOne Medicines, a pharmaceutical company based in Hopewell, New Jersey, is spending $300 million to expand its main manufacturing and
Pharmaceutical News
Eli Lilly to Acquire Company Developing Psychedelic Treatments for Hard-to-Treat Depression
Eli Lilly, a major pharmaceutical company, is spending $2.8 billion to acquire AtaiBeckley, a biopharmaceutical company working on new treatments
New Hope for Lynch Syndrome Carriers: Promising Cancer Prevention Therapy Presented at Major Medical Conference
A new cancer prevention therapy called NOUS-209 will be discussed at the European Society for Medical Oncology Congress in 2026.
Pharmaceutical Company Sells Kidney Drug to Australian Firm for Up to $292 Million
Mission Therapeutics, a biotechnology company based in Cambridge, has agreed to sell its kidney drug MTX652 to Dimerix Limited, an
New Study Begins for a Novel Treatment to Control High Phosphate Levels in Dialysis Patients
R1 Therapeutics has started a global phase 2b clinical trial for a new medication called AP306, designed to treat high